American Healthcare REIT Analyst Price Targets

Wall Street analyst price targets and consensus rating for American Healthcare REIT (AHR).

Price Target Range — 12 Quarters

Analyst Consensus — 16 Analysts

4S.Buy

12Buy

Consensus RatingBuy# Analysts16Avg. Consensus PT$50Upside to Avg. PT-6.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 13, 2026	UBS	Michael Goldsmith	PT Cut	Buy	$63→$62
Oct 13, 2026	Barclays	Richard Hightower	PT Cut	Overweight	$66→$60
Oct 13, 2026	Raymond James	David Rodgers	Initiate	Strong Buy	$62
Sep 2, 2026	Scotiabank	Nicholas Yulico	PT Raise	Sector Outperform	$56→$62
Aug 31, 2026	Barclays	Richard Hightower	PT Raise	Overweight	$61→$66
Aug 19, 2026	Keybanc	Austin Wurschmidt	PT Raise	Overweight	$58→$68
Aug 14, 2026	Truist Securities	Michael Lewis	PT Raise	Buy	$57→$61
Aug 14, 2026	RBC Capital	Michael Carroll	PT Raise	Outperform	$56→$61
Aug 13, 2026	Citigroup	Nick Joseph	PT Raise	Buy	$55→$65
Jul 27, 2026	Citizens	Aaron Hecht	PT Raise	Market Outperform	$60→$65
Jul 21, 2026	Compass Point	Rob Simone	Initiate	Buy	$70
Jul 8, 2026	UBS	Michael Goldsmith	PT Raise	Buy	$60→$63
Jul 7, 2026	Barclays	Richard Hightower	Initiate	Overweight	$61
Jun 23, 2026	Citigroup	Nick Joseph	Upgrade	Neutral→Buy	$55
Jun 18, 2026	Scotiabank	Nicholas Yulico	PT Cut	Sector Outperform	$59→$51
May 28, 2026	Keybanc	Austin Wurschmidt	PT Raise	Overweight	$55→$58
May 26, 2026	RBC Capital	Michael Carroll	PT Raise	Outperform	$54→$56
Mar 13, 2026	Truist Securities	Michael Lewis	PT Raise	Buy	$52→$57
Mar 11, 2026	Scotiabank	Nicholas Yulico	PT Raise	Sector Outperform	$55→$59
Mar 2, 2026	Citigroup	Nick Joseph	PT Raise	Neutral	$52→$55

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62

UBS analyst Michael Goldsmith maintains American Healthcare REIT (NYSE:AHR) with a Buy and lowers the price target from $63 to $62.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60

Barclays analyst Richard Hightower maintains American Healthcare REIT (NYSE:AHR) with a Overweight and lowers the price target from $66 to $60.

Benzinga Newsdesk

This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Analysts initiated coverage on NHP (Outperform, $20), OIG (Buy, $13), ETRA (Overweight), AHR (Strong Buy, $62).

Avi Kapoor

PRO
Raymond James Initiates Coverage On American Healthcare REIT with Strong Buy Rating, Announces Price Target of $62

Raymond James analyst David Rodgers initiates coverage on American Healthcare REIT (NYSE:AHR) with a Strong Buy rating and announces Price Target of $62.

Benzinga Newsdesk

PRO
Scotiabank Maintains Sector Outperform on American Healthcare REIT, Raises Price Target to $62

Scotiabank analyst Nicholas Yulico maintains American Healthcare REIT (NYSE:AHR) with a Sector Outperform and raises the price target from $56 to $62.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on American Healthcare REIT, Raises Price Target to $66

Barclays analyst Richard Hightower maintains American Healthcare REIT (NYSE:AHR) with a Overweight and raises the price target from $61 to $66.

Benzinga Newsdesk

American Healthcare REIT Inc

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

American Healthcare REIT Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
UBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62

PRO
Barclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60

This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

PRO
Raymond James Initiates Coverage On American Healthcare REIT with Strong Buy Rating, Announces Price Target of $62

PRO
Scotiabank Maintains Sector Outperform on American Healthcare REIT, Raises Price Target to $62

PRO
Barclays Maintains Overweight on American Healthcare REIT, Raises Price Target to $66

People Also Watch

People Also Watch

American Healthcare REIT Inc

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

American Healthcare REIT Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROUBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62

PROBarclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60

This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

PRORaymond James Initiates Coverage On American Healthcare REIT with Strong Buy Rating, Announces Price Target of $62

PROScotiabank Maintains Sector Outperform on American Healthcare REIT, Raises Price Target to $62

PROBarclays Maintains Overweight on American Healthcare REIT, Raises Price Target to $66

People Also Watch

People Also Watch

PRO
UBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62

PRO
Barclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60

PRO
Raymond James Initiates Coverage On American Healthcare REIT with Strong Buy Rating, Announces Price Target of $62

PRO
Scotiabank Maintains Sector Outperform on American Healthcare REIT, Raises Price Target to $62

PRO
Barclays Maintains Overweight on American Healthcare REIT, Raises Price Target to $66